Lumenis (LMNS) Misses Q1 EPS by 5c, Maintains FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Lumenis Ltd. Reports First Quarter Financial Results
May 12, 2015 4:05 PM EDTYOKNEAM, Israel, May 12, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (Nasdaq: LMNS), the world's largest energy-based medical company for surgical, ophthalmic and aesthetic applications, today announced first quarter of fiscal year 2015 financial results.
First Quarter Summary:
Revenues of $68.5 million, up 4.1% year-over-year on a reported basis, up 10.6% on a constant currency basis Adjusted EBITDA of $6.0 million, 8.7% of revenues, up 23.2% year-over-year Non-GAAP Net Income of $2.3 million, up 3.5% year-over-year. GAAP Net Income of $1.6 million Non-GAAP Net Income per diluted share of $0.06 $1.3... More